DC's Opioid Settlement Money Just Became a Medicaid Patch — And That's the Whole Scandal

Eighty individuals. Thirty organizations. One letter, sent to a city government, spelling out in plain language that its own budget breaks a promise written into the opioid settlement agreements themselves.

That’s the headline number from Washington DC’s FY2027 budget fight, and it’s worth sitting with before the jargon sets in. The District’s proposed budget applies roughly $2.3 million in opioid settlement funds toward its Medicaid contribution — and separately redirects at least $5.5 million that had been funding addiction-treatment centers, shifting that support into the general budget instead, according to KFF Health News. Recovery advocates and people with lived addiction experience packed a July 15 public meeting to say, essentially: you’re not supposed to do this.

This is not a technical budgeting dispute — it’s supplantation, the exact thing the settlements were written to prevent, and dressing it up as a Medicaid line item doesn’t change what it is.

Every opioid settlement agreement carries the same condition, because the lawyers who negotiated them anticipated exactly this move: money paid out by manufacturers, distributors, and pharmacy chains for their role in the overdose crisis is supposed to supplement addiction treatment and recovery spending, not supplant it — not replace dollars a city was already spending, and not backfill a budget hole somewhere else. DC’s plan does both at once. Settlement money covers a Medicaid obligation the District would have had to pay regardless, and general-fund dollars that used to go to treatment centers get pulled toward other priorities, according to WAMU’s corroborating reporting. Net effect: treatment funding holds flat or shrinks in a year when overdose deaths are still a live emergency, while the ledger technically shows settlement dollars “spent on health.”

The math is what makes the July meeting’s tone make sense. People who buried family members to get these settlements negotiated in the first place aren’t objecting to accounting mechanics — they’re objecting to watching the one guardrail meant to protect that money get treated as optional.

What makes this a story past the Beltway is the precedent, not the dollar amount. DC’s numbers are modest against the size of national settlement payouts, but the maneuver is portable: any jurisdiction facing a Medicaid shortfall or general-fund gap can look at a pool of earmarked opioid money sitting there and decide it’s easier to patch a budget hole than to build a new treatment bed. Nothing about DC’s math is unique to DC. That’s exactly why oversight bodies in other cities and counties — the ones deciding how their own settlement dollars get tagged this budget season — should be treating this fight as a preview, not a curiosity, and our policy and funding coverage will be tracking which of them do.

The settlement checks arrived with a condition attached in the fine print: additional, not instead-of. DC’s budget is the first clean test of whether anyone is actually going to enforce it, and right now the answer written into the ledger is no.